PE9296A1 - Forma polimorfica cristalina de (s,s,s)- n- (1-[ 2- carboxi- 3-(n�- mesil- lisilamino) propil]- 1-ciclopentil carbonil )tirosina (forma o) y procesos de obtencion - Google Patents
Forma polimorfica cristalina de (s,s,s)- n- (1-[ 2- carboxi- 3-(n�- mesil- lisilamino) propil]- 1-ciclopentil carbonil )tirosina (forma o) y procesos de obtencionInfo
- Publication number
- PE9296A1 PE9296A1 PE1994255868A PE25586894A PE9296A1 PE 9296 A1 PE9296 A1 PE 9296A1 PE 1994255868 A PE1994255868 A PE 1994255868A PE 25586894 A PE25586894 A PE 25586894A PE 9296 A1 PE9296 A1 PE 9296A1
- Authority
- PE
- Peru
- Prior art keywords
- processes
- lisilamino
- mesil
- propil
- carboxi
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C311/06—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Ophthalmology & Optometry (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Reproductive Health (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Peptides Or Proteins (AREA)
- Pyrrole Compounds (AREA)
Abstract
SE REFIERE A LA FORMA O DE UN COMPUESTO DE FORMULA I CON ESPECTRO I.R. CON BANDA DE ABSORCION DE 34O7 CM-1 A 655 CM-1 Y PATRON DE DIFRACCION DE RAYOS X DE POLVOS CON PICOS TAL COMO 7,5 GRADOS 2U A 23,3 GRADOS 2U, CALORIMETRIA DE BARRIDO DIFERENCIAL CON ENDOTERMIA AGUDA EN EL RANGO 248�C A 259�C FUNDIENDOSE EN INTERVALO DE 242�C A 250�C. LA FORMA O SE PUEDE PREPARAR USANDO FORMAS �, � Y FORMA � POLIMORFICA MEDIANTE: A) HIDROGENACION CATALITICA DE UNA DISOLUCION ACUOSA USANDO UN CATALIZADOR TAL COMO PALADIO SOBRE CARBONO, ACIDIFICACION A pH=4 y T=35�C A 45�C B) DISOLUCION ACUOSA DE SAL SODICA O POTASICA CON ACETATO DE ETILO,HIDROXIDO DE SODIO, USANDO UN CATALIZADOR TAL COMO PALADIO, PRECIPITANDO LA FORMA O POR AJUSTE DE LA ACIDEZ C) A PARTIR DE � POR AGITACION CON AGUA O DISOLUCION ACUOSA DE SOLVENTE ORGANICO, AGITANDO Y RECOGIENDO EL PRECIPITADO POR FILTRACION
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939324931A GB9324931D0 (en) | 1993-12-04 | 1993-12-04 | Glutaramide derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE9296A1 true PE9296A1 (es) | 1996-04-04 |
Family
ID=10746163
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1994255868A PE9296A1 (es) | 1993-12-04 | 1994-11-28 | Forma polimorfica cristalina de (s,s,s)- n- (1-[ 2- carboxi- 3-(n�- mesil- lisilamino) propil]- 1-ciclopentil carbonil )tirosina (forma o) y procesos de obtencion |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6180665B1 (es) |
| EP (1) | EP0731787B1 (es) |
| JP (1) | JP2701988B2 (es) |
| KR (1) | KR100203314B1 (es) |
| CN (1) | CN1068586C (es) |
| AT (1) | ATE175664T1 (es) |
| CA (1) | CA2178085C (es) |
| CZ (1) | CZ296428B6 (es) |
| DE (1) | DE69416003T2 (es) |
| DK (1) | DK0731787T3 (es) |
| EG (1) | EG20562A (es) |
| ES (1) | ES2128031T3 (es) |
| FI (1) | FI120305B (es) |
| GB (1) | GB9324931D0 (es) |
| GR (1) | GR3029590T3 (es) |
| HU (1) | HU225959B1 (es) |
| IL (1) | IL111791A (es) |
| MY (1) | MY115430A (es) |
| NO (1) | NO306714B1 (es) |
| NZ (1) | NZ276087A (es) |
| PE (1) | PE9296A1 (es) |
| PL (1) | PL178559B1 (es) |
| RU (1) | RU2131869C1 (es) |
| TW (2) | TW534901B (es) |
| WO (1) | WO1995015308A1 (es) |
| ZA (1) | ZA949595B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2420043A1 (en) | 2000-08-29 | 2002-03-07 | Riverside Forest Products Limited | Collapsible bin |
| FR2824477B1 (fr) * | 2001-05-09 | 2005-09-09 | Ethypharm Lab Prod Ethiques | Granules enrobes a base d'inhibiteur de l'enzyme de conversion de l'anfiotensine, leur procede de preparation et comprimes orodispersibles contenant les granules enrobes |
| US6975515B2 (en) | 2001-08-15 | 2005-12-13 | Agilent Technologies, Inc. | Electrical module |
| EP1592668A1 (en) * | 2003-02-12 | 2005-11-09 | Ciba SC Holding AG | Crystalline forms of pitavastatin calcium |
| WO2005123702A1 (en) * | 2004-06-15 | 2005-12-29 | Pfizer Limited | Neutral endopeptidase inhibitor polymorph |
| CN109350736A (zh) * | 2018-09-20 | 2019-02-19 | 南通大学 | 防治运动病、梅尼埃病的药物及心房钠尿肽的医药用途 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8820844D0 (en) * | 1988-09-05 | 1988-10-05 | Pfizer Ltd | Therapeutic agents |
| US5208236A (en) | 1992-09-23 | 1993-05-04 | Schering Corporation | N-(acylaminomethyl)glutaryl amino acids and use |
-
1993
- 1993-12-04 GB GB939324931A patent/GB9324931D0/en active Pending
-
1994
- 1994-11-07 TW TW089110999A patent/TW534901B/zh not_active IP Right Cessation
- 1994-11-07 TW TW083110283A patent/TW434210B/zh not_active IP Right Cessation
- 1994-11-09 CA CA002178085A patent/CA2178085C/en not_active Expired - Fee Related
- 1994-11-09 CZ CZ0160496A patent/CZ296428B6/cs not_active IP Right Cessation
- 1994-11-09 WO PCT/EP1994/003750 patent/WO1995015308A1/en active IP Right Grant
- 1994-11-09 EP EP95900719A patent/EP0731787B1/en not_active Expired - Lifetime
- 1994-11-09 NZ NZ276087A patent/NZ276087A/en not_active IP Right Cessation
- 1994-11-09 AT AT95900719T patent/ATE175664T1/de not_active IP Right Cessation
- 1994-11-09 CN CN94194942A patent/CN1068586C/zh not_active Expired - Fee Related
- 1994-11-09 JP JP7515356A patent/JP2701988B2/ja not_active Expired - Fee Related
- 1994-11-09 HU HU9601506A patent/HU225959B1/hu not_active IP Right Cessation
- 1994-11-09 DK DK95900719T patent/DK0731787T3/da active
- 1994-11-09 ES ES95900719T patent/ES2128031T3/es not_active Expired - Lifetime
- 1994-11-09 US US08/648,001 patent/US6180665B1/en not_active Expired - Fee Related
- 1994-11-09 DE DE69416003T patent/DE69416003T2/de not_active Expired - Lifetime
- 1994-11-09 RU RU96115251A patent/RU2131869C1/ru not_active IP Right Cessation
- 1994-11-09 KR KR1019960702912A patent/KR100203314B1/ko not_active IP Right Cessation
- 1994-11-09 PL PL94314794A patent/PL178559B1/pl not_active IP Right Cessation
- 1994-11-28 IL IL11179194A patent/IL111791A/en not_active IP Right Cessation
- 1994-11-28 PE PE1994255868A patent/PE9296A1/es not_active Application Discontinuation
- 1994-11-29 MY MYPI94003169A patent/MY115430A/en unknown
- 1994-12-01 EG EG75294A patent/EG20562A/xx active
- 1994-12-02 ZA ZA949595A patent/ZA949595B/xx unknown
-
1996
- 1996-06-03 FI FI962322A patent/FI120305B/fi not_active IP Right Cessation
- 1996-06-04 NO NO962294A patent/NO306714B1/no not_active IP Right Cessation
-
1999
- 1999-03-05 GR GR990400677T patent/GR3029590T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG103485A (en) | Ketobanzamides as calpain inhibitors | |
| CA2414018A1 (en) | 2-aminocarbonyl-9h-purine derivatives | |
| EA200200510A1 (ru) | 4-карбоксиамино-2-этил-1,2,3,4-тетрагидрохинолин в кристаллической форме как ингибитор сетр | |
| YU41199A (sh) | Hinoksalindioni | |
| NZ279397A (en) | Mercaptoacetylamido 1,3,4,5-tetrahydro-benzo[c]azepin-3-one disulfide derivatives and pharmaceutucal compositions | |
| IL160045A0 (en) | Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of levetiracetam and analogues | |
| CA2107223A1 (en) | Crystalline tiagabine hydrochloride monohydrate, its preparation and use | |
| FI942457A (fi) | Substituoitujen piperidiinien valmistus | |
| ES2093099T3 (es) | Preparacion de piperidinas sustituidas. | |
| NZ331875A (en) | Asymmetric synthesis of R-alpha-propyl-piperonyl amine and its analogs | |
| PE9296A1 (es) | Forma polimorfica cristalina de (s,s,s)- n- (1-[ 2- carboxi- 3-(n�- mesil- lisilamino) propil]- 1-ciclopentil carbonil )tirosina (forma o) y procesos de obtencion | |
| WO2003080631A3 (en) | Plasma carboxypeptidase b inhibitors | |
| MY129094A (en) | Condensed polycyclic compounds | |
| ATE282608T1 (de) | Chinoxalindionen | |
| IL159493A0 (en) | Pharmaceutical formulation containing an ltb4 antagonist | |
| BR0112849A (pt) | Processo para a preparação de um composto quiral, e, composto quiral | |
| BR9915898A (pt) | Compostos, composição farmacêutica, e, utilização de um composto | |
| HUP0203476A2 (en) | Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-(2-(3,4-dimethoxyphenyl)ethoxy)-3,3-diphenylpropionate, use thereof and pharmaceutical composition containing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |